Moneycontrol PRO

business

US court lets off Ranbaxy in antitrust case; stock up 1.8%

Shares in homegrown pharmaceuticals firm Ranbaxy Labs rose 1.8 percent in early Mumbai trading after a US federal court ruled in its favour in a landmark “pay-to-delay” case.

first published: Dec 8, 2014 11:30 am

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
CloseOutskill Genai